Two years ago, almost without warning, a global pandemic shook the world, and in an instant, made its citizens reconsider and reassess what is most important to us. Fear and forced isolation put family, friends and work-life balance at the top of this reassessment, and corporations now have some reevaluating of their own to do […]

Shoreline Biosciences has poached the leader of Pfizer’s cancer vaccines unit, Robert Hollingsworth, Ph.D., to serve as chief scientific officer for the startup, which has recently beefed up its leadership, financing and partnerships. Hollingsworth was chief scientific officer and vice president of cancer vaccines and immunotherapies at the New York Big Pharma, where he helped bring […]

Cell-based therapies can be developed in various ways, but companies look for methods that are faster and more efficient. At Houston, TX-based FibroBiologics scientists turn fibroblasts into potentially therapeutic uses. Hamid Khoja, PhD, chief scientific officer at FibroBiologics, calls fibroblasts “one of the most abundant cells in the human body.” He adds, “They can differentiate […]